Ligand validation:4BVN

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 4BVN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BVN_OLC_A_2005	28%	81%	0.161	0.873	0.23	0.58	-	-	0	0	68%	0.34
4BVN_OLC_A_2004	17%	38%	0.179	0.859	1.27	1.25	2	1	0	0	44%	0.44
4BVN_OLC_A_2007	16%	51%	0.18	0.803	1.14	0.78	1	1	3	0	68%	0.68
4BVN_OLC_A_2001	15%	52%	0.182	0.776	1.09	0.79	1	1	1	0	80%	0.8
4BVN_OLC_A_2003	13%	36%	0.209	0.816	1.51	1.11	2	1	1	0	64%	0.64
4BVN_OLC_A_2006	9%	50%	0.248	0.738	0.96	0.97	1	2	1	0	100%	0.5
4BVN_OLC_A_2002	6%	55%	0.23	0.661	0.97	0.74	1	1	0	0	100%	1
5A8E_OLC_A_2003	22%	39%	0.19	0.894	1.45	1.02	2	-	0	0	52%	0.26
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.